GO:0072161 mesenchymal cell differentiation involved in kidney development: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072161 describes the process by which unspecialized cells acquire the specialized structural and functional features of kidney mesenchymal cells during kidney development.
• This process is essential for the formation of the metanephric mesenchyme, which gives rise to most epithelial cell types of the mature nephron.
• Key signaling pathways include EGF receptor signaling, which regulates organ development and tissue homeostasis, and matrix metalloproteinases that remodel the extracellular matrix during renal development.
• Epithelial-mesenchymal-epithelial cycling is a related process critical for kidney repair and may share molecular players with developmental mesenchymal differentiation.
• Dysregulation of mesenchymal differentiation programs contributes to kidney fibrosis through endothelial-to-mesenchymal transition and is implicated in cancers such as those involving BCOR mutations.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes driving mesenchymal cell differentiation in kidney development.
Description
Mesenchymal cell differentiation involved in kidney development (GO:0072161) is a biological process that encompasses the steps by which relatively unspecialized cells acquire the specialized structural and functional features characteristic of kidney mesenchymal cells as the organ progresses from formation to maturity. This process is fundamental to nephrogenesis, as the metanephric mesenchyme contains progenitor cells that ultimately differentiate into the diverse epithelial cell types of the nephron. Understanding this process is critical for developmental biologists and clinicians because defects in mesenchymal differentiation underlie congenital kidney anomalies and contribute to fibrotic and neoplastic diseases. Recent research has highlighted the role of signaling pathways such as EGF receptor signaling in organ development and regeneration, as well as the involvement of matrix metalloproteinases in extracellular matrix remodeling during renal development. Moreover, the plasticity of mesenchymal cells is evident in epithelial-mesenchymal-epithelial cycling during kidney repair, and in pathological contexts such as endothelial-to-mesenchymal transition in kidney fibrosis. The study of GO:0072161 therefore provides a framework for understanding both normal kidney formation and the molecular underpinnings of renal disease.
mesenchymal cell differentiation involved in kidney development At A Glance
| GO ID | GO:0072161 |
|---|---|
| GO term | mesenchymal cell differentiation involved in kidney development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Differentiation of unspecialized cells into kidney mesenchymal cells during development |
| Related processes | Kidney development, mesenchymal cell differentiation, epithelial-mesenchymal transition |
| Key signaling pathways | EGF receptor signaling, matrix metalloproteinase activity, IL-33/ST2 axis |
| Associated genes | EGFR, BCOR, TRPS1, MMPs, and others |
| Disease relevance | Kidney fibrosis, congenital anomalies, cancer |
What Is GO:0072161?
According to the Gene Ontology, GO:0072161 (mesenchymal cell differentiation involved in kidney development) is defined as the process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mesenchymal cells of the kidney as it progresses from its formation to the mature state. In simpler terms, it is the developmental program that turns generic progenitor cells into the specific mesenchymal cell types required for building and maturing the kidney.
Why Is mesenchymal cell differentiation involved in kidney development Important in Cell Biology?
GO:0072161 is important because it defines a critical developmental window during which the kidney's mesenchymal progenitors are specified and differentiated. Disruption of this process leads to structural and functional kidney defects, and reactivation of mesenchymal differentiation programs contributes to fibrosis and cancer. Understanding the molecular regulation of this process can inform regenerative medicine strategies and identify therapeutic targets for kidney diseases.
• Provides the cellular basis for nephron formation and kidney maturation.
• Dysregulation is linked to congenital anomalies of the kidney and urinary tract.
• Mesenchymal differentiation pathways are reactivated in kidney fibrosis via endothelial-to-mesenchymal transition.
• Matrix metalloproteinases involved in renal development also play roles in tissue remodeling and disease.
• EGF receptor signaling, a key regulator of organ development, influences mesenchymal differentiation.
• BCOR mutations are associated with cancers and may affect mesenchymal differentiation.
• TRPS1 is critical for bone, kidney, and hair follicle development, highlighting shared mechanisms.
• IL-33/ST2 axis is implicated in organ fibrosis and may intersect with mesenchymal differentiation.
• Epithelial-mesenchymal-epithelial cycling is essential for kidney repair and shares molecular features.
• CRISPR screening can identify novel regulators of this process for therapeutic targeting.
What Happens During mesenchymal cell differentiation involved in kidney development?
Specification of the metanephric mesenchyme
In simple terms: The kidney's precursor cells are told to become kidney-specific mesenchymal cells.
During early kidney development, a population of cells in the intermediate mesoderm is specified to form the metanephric mesenchyme. This specification involves inductive signals from the ureteric bud and surrounding tissues, leading to the expression of transcription factors that commit cells to the kidney mesenchymal lineage. The process is tightly regulated by signaling pathways including EGF receptor signaling, which influences organ development and tissue homeostasis.
Mesenchymal-to-epithelial transition (MET)
In simple terms: Mesenchymal cells change into epithelial cells to form nephron structures.
A key step in kidney development is the mesenchymal-to-epithelial transition (MET), where condensed mesenchymal cells aggregate and undergo morphological and molecular changes to become epithelial renal vesicles. This transition is driven by the coordinated expression of adhesion molecules, cytoskeletal rearrangements, and transcription factors such as WT1 and Pax2. Matrix metalloproteinases facilitate the remodeling of the extracellular matrix necessary for this transition.
Extracellular matrix remodeling
In simple terms: The scaffold around cells is broken down and rebuilt to allow tissue shaping.
Matrix metalloproteinases (MMPs) are critical for degrading and remodeling the extracellular matrix during kidney development. They enable cell migration, branching morphogenesis, and the structural changes required for mesenchymal differentiation. Dysregulation of MMP activity can lead to abnormal kidney development and has been implicated in fibrotic processes.
Signaling pathways regulating differentiation
In simple terms: Chemical signals tell the cells when to differentiate and what to become.
Multiple signaling pathways converge to regulate mesenchymal cell differentiation in the kidney. EGF receptor signaling is essential for organ development and regeneration, affecting cell proliferation, survival, and differentiation. The IL-33/ST2 axis has been implicated in organ fibrosis and may influence mesenchymal cell behavior. Additionally, epithelial-mesenchymal-epithelial cycling, which involves reversible transitions, is important for kidney repair and shares molecular players with developmental processes.
Transcriptional control of mesenchymal differentiation
In simple terms: Master switches inside the cell turn genes on or off to drive differentiation.
Transcription factors such as TRPS1 play critical roles in the development and differentiation of bone, kidney, and hair follicles. BCOR, a transcriptional corepressor, is involved in cancer and may influence mesenchymal differentiation programs. These factors coordinate the expression of genes required for mesenchymal cell identity and function.
Key Genes Involved in GO:0072161 mesenchymal cell differentiation involved in kidney development
The following genes and proteins have been experimentally linked to mesenchymal cell differentiation involved in kidney development or related processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EGFR | Regulates organ development, tissue homeostasis, and regeneration | Implicated in kidney development and repair |
| BCOR | Transcriptional corepressor involved in cancer | May influence mesenchymal differentiation and cancer progression |
| TRPS1 | Transcription factor critical for bone, kidney, and hair follicle development | Essential for kidney differentiation |
| MMP2 | Matrix metalloproteinase that degrades extracellular matrix | Facilitates renal development and remodeling |
| MMP9 | Matrix metalloproteinase involved in tissue remodeling | Plays a role in kidney development and fibrosis |
| IL33 | Cytokine involved in fibrosis and inflammation | May affect mesenchymal cells in kidney |
| ST2 (IL1RL1) | Receptor for IL-33 | Mediates IL-33 signaling in fibrosis |
| WT1 | Transcription factor essential for kidney development | Regulates mesenchymal-to-epithelial transition |
| PAX2 | Transcription factor required for kidney development | Controls mesenchymal differentiation |
| SIX1 | Transcription factor involved in kidney and muscle development | Regulates mesenchymal progenitor cells |
| SIX2 | Transcription factor maintaining nephron progenitors | Prevents premature differentiation |
| GDNF | Growth factor that induces ureteric bud branching | Signals to metanephric mesenchyme |
| FGF8 | Fibroblast growth factor involved in kidney development | Promotes mesenchymal survival and differentiation |
| BMP7 | Bone morphogenetic protein that promotes kidney development | Induces mesenchymal differentiation |
| WNT9B | Wnt ligand that signals to metanephric mesenchyme | Stimulates mesenchymal-to-epithelial transition |
| HGF | Hepatocyte growth factor that promotes cell motility | Involved in epithelial-mesenchymal interactions |
| TGFB1 | Transforming growth factor beta that induces EMT | Linked to fibrosis and mesenchymal differentiation |
How Is mesenchymal cell differentiation involved in kidney development Regulated?
The process of mesenchymal cell differentiation involved in kidney development is regulated by a complex network of signaling pathways and transcription factors. EGF receptor signaling modulates cell proliferation, survival, and differentiation during organ development. The IL-33/ST2 axis has been implicated in organ fibrosis and may influence mesenchymal cell behavior. Matrix metalloproteinases regulate the extracellular matrix environment, which in turn affects differentiation. Transcriptional regulators such as TRPS1 and BCOR coordinate gene expression programs necessary for mesenchymal differentiation. Additionally, epithelial-mesenchymal-epithelial cycling, involving reversible transitions, is tightly controlled during kidney repair.
mesenchymal cell differentiation involved in kidney development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCOR | Cancer, possibly sarcoma and leukemia | Knockout or point mutation in kidney mesenchymal cells |
| EGFR | Cancer, kidney fibrosis | Overexpression or knockout in renal progenitor cells |
| MMP2/MMP9 | Kidney fibrosis, developmental defects | Knockout mice or CRISPR-edited cell lines |
| IL33/ST2 | Organ fibrosis, inflammation | Knockout or overexpression in mesenchymal cells |
| TRPS1 | Skeletal and kidney abnormalities | Knockout models to study differentiation |
Kidney fibrosis and chronic kidney disease
Kidney fibrosis is characterized by excessive accumulation of extracellular matrix and is a common endpoint of chronic kidney disease. Endothelial-to-mesenchymal transition (EndMT) contributes to the pool of myofibroblasts in fibrotic kidneys, and this process shares molecular features with developmental mesenchymal differentiation. Matrix metalloproteinases, which are critical for normal kidney development, are also dysregulated in fibrosis. The IL-33/ST2 axis has been implicated in organ fibrosis, further linking developmental pathways to disease.
Cancer
BCOR mutations are found in various cancers and may affect mesenchymal differentiation programs. Dysregulation of developmental pathways, including EGF receptor signaling, is common in cancer, and EGF receptor is a well-known oncogene. Understanding how mesenchymal differentiation is controlled during kidney development may provide insights into tumorigenesis and identify therapeutic targets.
Congenital anomalies of the kidney and urinary tract (CAKUT)
Defects in mesenchymal cell differentiation during kidney development can lead to congenital anomalies such as renal agenesis, hypoplasia, and dysplasia. Mutations in genes like WT1, PAX2, and SIX1 are associated with CAKUT, highlighting the importance of proper mesenchymal differentiation for normal kidney formation.
From mesenchymal cell differentiation involved in kidney development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate mesenchymal differentiation? | CRISPR knockout in metanephric mesenchymal cells |
| Does a specific point mutation in gene Y affect differentiation? | CRISPR point mutation knock-in in kidney organoids |
| What is the effect of overexpressing gene Z? | CRISPR overexpression (e.g., CRISPRa) in renal progenitor cells |
| Where is protein W localized during differentiation? | Tagged knock-in (e.g., GFP) in kidney organoids |
| What is the transcriptional response to differentiation signals? | RNA-seq after CRISPR perturbation |
| Which genes are essential for mesenchymal differentiation? | Genome-wide CRISPR library screening in kidney organoids |
How to Study the mesenchymal cell differentiation involved in kidney development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression levels | Identify transcriptional changes during differentiation |
| Proteomics | Protein abundance and modifications | Discover signaling pathways and markers |
| ChIP-seq | Transcription factor binding sites | Map regulatory elements controlling differentiation |
| CRISPR knockout screening | Gene essentiality | Identify genes required for mesenchymal differentiation |
| CRISPR activation screening | Gene overexpression effects | Find genes that drive differentiation |
| Live-cell imaging | Cell behavior and morphology | Track differentiation in real time |
| Organoid culture | 3D tissue architecture | Model kidney development and disease |
Transcriptomic profiling (RNA-seq)
RNA sequencing can be used to compare gene expression profiles between undifferentiated mesenchymal cells and those undergoing differentiation. This approach identifies transcriptional programs and potential regulators of GO:0072161.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can quantify protein abundance and post-translational modifications during mesenchymal differentiation. This helps identify signaling pathways, such as EGF receptor signaling, that are activated.
Imaging and lineage tracing
Fluorescence microscopy and lineage tracing in model organisms (e.g., mice, zebrafish) allow visualization of mesenchymal cell behavior and differentiation in real time. This can reveal morphological changes and migration patterns.
CRISPR screening
Genome-wide CRISPR knockout or activation screens in kidney organoids or cell lines can identify genes that are essential or sufficient for mesenchymal cell differentiation. This unbiased approach can uncover novel regulators.
How CRISPR Can Be Used to Study GO:0072161 mesenchymal cell differentiation involved in kidney development
Knockout
CRISPR knockout (KO) is used to completely ablate a gene of interest to determine its necessity in mesenchymal cell differentiation. For example, knocking out EGFR in renal progenitor cells can reveal its role in proliferation and differentiation. KO models are also valuable for studying genes like BCOR and TRPS1.
Point Mutation
CRISPR point mutation (e.g., via base editing or homology-directed repair) introduces specific nucleotide changes to model disease-associated variants or to dissect functional domains of proteins. This is particularly useful for studying genes like BCOR where missense mutations are found in cancer.
Knock-in
CRISPR knock-in allows the insertion of reporter tags (e.g., GFP) or other sequences into endogenous loci to track protein expression and localization. Tagged knock-in of genes like WT1 or PAX2 can visualize their dynamics during mesenchymal differentiation.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression constructs can drive high-level expression of a gene to test sufficiency in inducing differentiation. Overexpressing EGF receptor or its ligands can promote mesenchymal differentiation.
How EDITGENE Supports mesenchymal cell differentiation involved in kidney development Research
Researchers studying mesenchymal cell differentiation involved in kidney development-related genes often need to determine whether a candidate gene is causally involved in the process. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies.
Contact EDITGENE today to design your custom CRISPR model for mesenchymal cell differentiation involved in kidney development research.
Frequently Asked Questions About mesenchymal cell differentiation involved in kidney development
What is GO:0072161?
GO:0072161 is the Gene Ontology term for mesenchymal cell differentiation involved in kidney development, describing how unspecialized cells become specialized kidney mesenchymal cells.
What genes are involved in mesenchymal cell differentiation involved in kidney development?
Key genes include EGFR, BCOR, TRPS1, MMP2, MMP9, IL33, WT1, PAX2, SIX1, SIX2, GDNF, FGF8, BMP7, WNT9B, HGF, and TGFB1.
Why is mesenchymal cell differentiation important for kidney development?
It is essential for forming the metanephric mesenchyme, which gives rise to most epithelial cells of the nephron, and defects lead to congenital kidney anomalies.
How is mesenchymal cell differentiation regulated?
It is regulated by signaling pathways such as EGF receptor signaling, IL-33/ST2 axis, matrix metalloproteinases, and transcription factors like TRPS1 and BCOR.
What diseases are associated with defects in this process?
Defects are linked to congenital anomalies of the kidney and urinary tract, kidney fibrosis, and cancers such as those with BCOR mutations.
What research methods are used to study GO:0072161?
Methods include RNA-seq, proteomics, imaging, CRISPR screening, and organoid culture.
How can CRISPR be used to study mesenchymal cell differentiation?
CRISPR knockout, point mutation, knock-in, and overexpression enable functional dissection of genes in kidney mesenchymal cells.
What is the role of EGFR in kidney development?
EGFR signaling regulates organ development, tissue homeostasis, and regeneration, influencing mesenchymal differentiation.
How does BCOR relate to kidney development?
BCOR is a transcriptional corepressor involved in cancer and may influence mesenchymal differentiation programs.
What are potential therapeutic targets for kidney fibrosis?
Genes involved in mesenchymal differentiation, such as MMPs, IL33/ST2, and TGFB1, are potential targets for anti-fibrotic therapies.
Conclusion
GO:0072161, mesenchymal cell differentiation involved in kidney development, is a fundamental biological process that underpins kidney formation and function. Its dysregulation contributes to congenital anomalies, fibrosis, and cancer. By leveraging CRISPR-based models and multi-omics approaches, researchers can dissect the molecular mechanisms governing this process and identify new therapeutic targets. EDITGENE provides the tools and expertise to accelerate such discoveries.
References
- 1. Tito C et al.. 2025. EGF receptor in organ development, tissue homeostasis and regeneration.. J Biomed Sci 32(1):24 PMID: 39966897
- 2. Astolfi A et al.. 2019. BCOR involvement in cancer.. Epigenomics 11(7):835-855 PMID: 31150281
- 3. Jacobs ME et al.. 2024. Endothelial to mesenchymal transition in kidney fibrosis.. Nephrol Dial Transplant 39(5):752-760 PMID: 37968135
- 4. Ishibe S et al.. 2008. Epithelial-mesenchymal-epithelial cycling in kidney repair.. Curr Opin Nephrol Hypertens 17(4):379-85 PMID: 18660674
- 5. Faa G et al.. 2012. Morphogenesis and molecular mechanisms involved in human kidney development.. J Cell Physiol 227(3):1257-68 PMID: 21830217
- 6. Kotsiou OS et al.. 2018. IL-33/ST2 Axis in Organ Fibrosis.. Front Immunol 9:2432 PMID: 30405626
- 7. Gai Z et al.. 2011. The function of TRPS1 in the development and differentiation of bone, kidney, and hair follicles.. Histol Histopathol 26(7):915-21 PMID: 21630221
- 8. Haas CS et al.. 2004. Matrix metalloproteinases in renal development.. Connect Tissue Res 45(2):73-85 PMID: 15763922
